Zomedica Corp. (OTCQB:ZOMDF), an animal health company focused on innovative diagnostic and therapeutic products, has announced a strategic partnership with Veterinary Management Groups (VMG), which serves over 2,000 veterinary practices in the United States. The agreement, effective from September 1, 2026, to August 31, 2028, designates Zomedica as a preferred provider of advanced veterinary solutions for VMG's member network.
Read More
As part of this collaboration, VMG members will receive preferred access to various Zomedica technologies. These include the PulseVet® shock wave therapy system, known for its effectiveness in veterinary care by delivering non-invasive, high-energy sound waves for healing and pain relief. Additional offerings include Assisi® targeted pulsed electromagnetic field (tPEMF™) therapy devices to manage pain and anxiety, VETIGEL® hemostatic gel for rapid blood clotting, the TRUFORMA® point-of-care diagnostic platform for endocrine testing, and the VETGuardian PLUS™ remote monitoring platform for real-time patient oversight.
Larry Heaton, CEO of Zomedica, expressed pride in partnering with VMG, highlighting the organization's commitment to supporting independent practices. He noted that the collaboration aims to enhance clinical excellence and patient-centered care.
Matt Salois, President of VMG, emphasized the mission to empower independent practices and improve care standards. He stated that integrating Zomedica's advanced technologies will provide clinics with necessary tools to excel in veterinary medicine, reinforcing their commitment to advancing veterinary practice and supporting member success.